Links
[1] https://www.msh.org/resources/implementing-an-integrated-pharmaceutical-management-information-system-for
[2] https://www.msh.org/resources/the-challenge-of-rapid-management-of-fever-in-children-under-5-in-guinea
[3] https://www.msh.org/resources/an-analysis-of-policies-for-cotrimoxazole-amoxicillin-and-azithromycin-use-in-namibias
[4] https://www.msh.org/resources/engagement-of-the-private-pharmaceutical-sector-for-tb-control-rhetoric-or-reality
[5] https://www.msh.org/resources/individual-capacity-building-approaches-in-a-global-pharmaceutical-systems-strengthening
[6] https://www.msh.org/resources/user-experience-analysis-of-e-tb-manager-a-nationwide-electronic-tuberculosis-recording
[7] https://www.msh.org/resources/user-experience-analysis-of-an-ehealth-system-for-tuberculosis-in-resource-constrained
[8] https://www.msh.org/resources/active-surveillance-versus-spontaneous-reporting-for-first-line-antiretroviral-medicines
[9] https://www.msh.org/resources/sentinel-site-active-surveillance-of-safety-of-first-line-antiretroviral-medicines-in
[10] https://www.msh.org/resources/strategies-based-on-evidence-to-rationalize-the-high-cost-drugs-national-list-in-the